IRF4 expression is inversely correlated with clinical outcome of myeloma (Heintel et al., 2008) and IRF4-dependent modulation of Fas-induced apoptosis governs, in part, myeloma survival (Fanzo et al., 2006). The gene discussed is FAS; the disease is plasma cell myeloma.